Texas Biomed to test CBD/THC against HIV-induced neurological disorder

San Antonio, Texas (December 11, 2020) – The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND). This research project aims to evaluate whether delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)…

Political partisanship has had outsized influence on individual social mobility during COVID-19 pand

In the United States, political partisanship has played a much stronger role in individuals’ decisions to limit their social mobility during the COVID-19 pandemic than the local incidence of the disease in their own communities, according to a new survey-based study of 1,135,638 million responses collected between April 4 and September 10, 2020 via Survey…

A saliva-based smartphone platform could rapidly expand COVID-19 testing

Offering an ultrasensitive yet accessible approach to COVID-19 testing, a portable saliva-based smartphone platform provides results within 15 minutes without the resource-intensive laboratory tests the current gold standard requires, according to a new study. The approach was tested in 12 people infected with COVID-19 and 6 healthy controls. Bo Ning and colleagues demonstrate that this…

Pre-existing flu immunity impacts antibody quality following infection and vaccination

New research by scientists at the University of Chicago suggests a person’s antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected. Their results highlight the importance of receiving the annual flu vaccine to induce the most…